Sorted news

Valeant, Ackman make $45.6B Allergan bid

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

20 hours ago
popularity not rated yet | comments 0

The ABC's of managing your medications

If you take several prescription medications, over-the-counter products, or herbal supplements for various medical conditions, it can be difficult to manage. According to the Centers for Disease Control and ...

22 hours ago
popularity not rated yet | comments 0